Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy - Related Studies

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

This study has been completed.

Study NCT00003600. Last updated on November 16, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Cancer
		Cancer-Related Problem/Condition
		Leukemia
		Lung Cancer
		Lymphoma
		Precancerous/Nonmalignant Condition
		Small Intestine Cancer

2	Additional conditions recognized in this trial
		Breast Neoplasms
		Duodenal Neoplasms
		Ileal Neoplasms
		Intestinal Neoplasms
		Jejunal Neoplasms
		Lung Neoplasms
		Lymphoma, Non-Hodgkin
		Multiple Myeloma
		Myeloproliferative Disorders
		Neoplasms, Plasma Cell
		Precancerous Conditions

3	More general conditions related to this trial
		Blood Protein Disorders
		Bone Marrow Diseases
		Breast Diseases
		Cardiovascular Diseases
		Digestive System Diseases
		Digestive System Neoplasms
		Duodenal Diseases
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Hematologic Diseases
		Hemorrhagic Disorders
		Hemostatic Disorders
		Ileal Diseases
		Immune System Diseases
		Immunoproliferative Disorders
		Intestinal Diseases
		Jejunal Diseases
		Lung Diseases
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Paraproteinemias
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Skin Diseases
		Thoracic Neoplasms
		Vascular Diseases

4	Interventions listed in this trial
		epoetin alfa
		quality-of-life assessment

5	More general drug interventions related to this trial
		Hematinics
		Hematologic Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		North Central Cancer Treatment Group
		National Cancer Institute (NCI)